A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs

BJU International

Volumn 108, Issue SUPPL.2, 2011, Pages 45-50

  Taylor, Kellie ^a   Filgate, Rhys ^a   Guo, Ding Yu ^a   MacNeil, Finlay ^a  

^a Central Coast AHA   (Australia)

Author keywords

anticoagulant; antiplatelet; aspirin; transurethural prostatectomy; warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; CLOPIDOGREL; WARFARIN;

ACUTE CORONARY SYNDROME; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGICAL COMPLICATION; PERIOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SURGICAL RISK; TRANSIENT ISCHEMIC ATTACK; TRANSURETHRAL RESECTION; TREATMENT WITHDRAWAL;

AGED; ANTICOAGULANTS; ASPIRIN; BLOOD LOSS, SURGICAL; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; HUMANS; MALE; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TRANSURETHRAL RESECTION OF PROSTATE; WARFARIN;

EID: 81455154765     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10686.x     Document Type: Article

References (32)

1. Thurston AV, Briant SL,. Aspirin and post-prostatectomy haemorrhage. Br J Urol 1993; 71: 874
2. Watson CJE, Deane AM, Doyle PT, Bullock KN,. Identifiable factors in post-prostatectomy haemorrhage: the role of aspirin. Br J Urol 1990; 66: 85-7 (Pubitemid 20228003)
3. Choi YD, Ham WS, Kim WT, Yang WJ, Koo KC, Ju HJ,. Outcome of urologic surgeries in the patients continuing antiplatelet drugs. J Urol 2009; 181 (Suppl. 1): 463
4. Donat R, Wilson I, Raza A, Byrne DJ, Smith G, Stewart LH,. A multicentre prospective, randomised, doubleblind placebo-controlled trial of aspirin during transurethral resection of the prostate (TURP). J Urol 2003; 169 (Suppl.): 466-7
5. Nielsen JD, Holm-Nielsen A, Jespersen J, Vinther CC, Settgast IW, Gram J,. The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy: a prospective, randomized, double-blind, placebo-controlled study. Scand J Urol Nephrol 2000; 34: 194-8 (Pubitemid 32055269)
6. Burger W, Chemnitius JM, Kneissl GD, Rucker G,. Low-dose aspirin for secondary cardiovascular prevention-cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation-review and meta-analysis. J Int Med 2005; 257: 399-414 (Pubitemid 40604544)
7. Parr NJ, Loh CS, Desmond AD,. Transurethral resection of the prostate and bladder tumour without withdrawal of warfarin therapy. Br J Urol 1989; 64: 623-5 (Pubitemid 20040265)
8. Ala-Opas MY, Gronlund SS,. Blood loss in long-term aspirin users undergoing transurethral prostatectomy. Scand J Urol Nephrol 1995; 30: 203-6 (Pubitemid 26228182)
9. Ehrlich Y, Yossepowitch O, Margel D, Lask D, Livne PM, Baniel J,. Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trial. J Urol 2007; 178: 524-8 (Pubitemid 47030512)
10. Wierød FS, Frandsen NJ, Jacobsen JD, Hartvigsen A, Olsen PR,. Risk of haemorrhage from transurethral prostatectomy in acetylsalylic acid and NSAID-treated patients. Scand J Urol Nephrol 1998; 32: 120-2 (Pubitemid 28206805)
11. Enver MK, Hoh I, Chinegwundoh F,. The management of aspirin in transurethral prostatectomy: current practice in the UK. Ann R Coll Surg Engl 2006; 88: 280-3
12. Mukerji G, Munasinghe I, Raza A,. A survey of the peri-operative management of urological patients on clopidogrel. Ann R Coll Surg Engl 2009; 91: 313-20
13. Shahar E, Folsom AR, Romm FJ, et al,. Patterns of aspirin use in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 1996; 131: 915-22 (Pubitemid 26135754)
14. Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al,. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 2006; 27: 2667-74 (Pubitemid 44729867)
15. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86
16. Bell CRW, Murdock PJA, Pasi KJ, Morgan RJ,. Thrombotic risk factors associated with transurethral prostatectomy. BJU Int 1999; 83: 984-9 (Pubitemid 29271864)
17. Douketis JD, Berger PB, Dunn AS, et al,. The Perioperative Management of Antithrombotic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, 8th edn. In Chest 2008; 133: 299S-339S (Pubitemid 351894915)
18. Hart RG, Benavente O, McBride R, Pearce LA,. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999; 131: 492-501 (Pubitemid 29482392)
19. Jaffer AK, Brotman DJ, Bash LD, Mahmood SK, Lott B, White RH,. Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals. Am J Med 2010; 123: 141-50
20. White RH, McKittrick T, Hutchinson R, Twitchell J,. Temporary discontinuation of warfarin therapy: changes in the international normalized ratio. Ann Intern Med 1995; 122: 40-2
21. Chassot PG, Delabays A, Spahn DR,. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaes 2007; 99: 316-28 (Pubitemid 47321534)
22. Mitchell SM, Sethia KK,. Hazards of aspirin withdrawal before transurethral prostatectomy. BJU Int 1999; 71: 874
23. Descazeaud A, Robert G, Lebdai S, et al,. Impact of oral anticoagulation on morbidity of transurethral resection of the prostate. World J Urol 2011; 29: 211-6
24. Eberli D, Chassot PG, Sulser T, et al,. Urological surgery and antiplatelet drugs after cardiac and cerebrovascular accidents. J Urol 2010; 183: 2128-36
25. Vasudeva P, Goel A, Sengottayan VK, Sankhwar S, Dalela D,. Antiplatelet drugs and the perioperative period: what every urologist needs to know. Indian J Urol 2009; 25: 296-301
26. Hoffman RM, MacDonald R, Wilt TJ,. Laser prostatectomy for benign prostatic obstruction. Cochrane Database Syst Rev 2004; 1: CD001987
27. Hoffman RM, Monga M, Elliott SP, MacDonald R, Wilt T,. Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database of Syst Rev 2007; 4: CD004135
28. Webber R,. Benign prostatic hyperplasia. Clin Evid 2006; 15: 1213-26
29. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T,. High potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005; 173: 158-60 (Pubitemid 39627700)
30. Elzayat E, Habib E, Elhilali M,. Holmium laser enucleation of the prostate in patients on anticoagulant therapy or with bleeding disorders. J Urol 2006; 175: 1428-32
31. Ruszat R, Wyler S, Forster T, et al,. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 2007; 51: 1031-41 (Pubitemid 46281412)
32. Descazeaud A, Robert G, Azzousi AR, et al,. Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review. BJU Int 2009; 103: 1162-5